Response to the letter titled reply to "Associations of semaglutide with first-time diagnosis of Alzheimer's disease in patients with type 2 diabetes: Target trial emulation using nationwide real-world data in the US".
第一作者:
Rong,Xu
第一单位:
Center for Artificial Intelligence in Drug Discovery, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
作者:
DOI
10.1002/alz.14611
PMID
39950490
发布时间
2025-02-16
- 浏览0

Alzheimer's & dementia
e14611页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文